Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
Titel:
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT)
Auteur:
Sheng, Xinan Ye, Dingwei Zhou, Aiping Yao, Xin Luo, Hong He, Zhisong Wang, Zengjun Zhao, Yingchao Ji, Zhigang Zou, Qing He, Chaohong Guo, Jianming Tu, Xinhua Liu, Ziling Shi, Benkang Liu, Ben Chen, Peng Wei, Qiang Hu, Zhiquan Zhang, Yanqiao Jiang, Kui Zhou, Fangjian Wu, Dapeng Fu, Cheng Li, Xingya Wu, Bin Wang, Lijie Qin, Shukui Li, Gang Liu, Yunpeng Guo, Hongqian Chen, Kehe Zhang, Dahong Wang, Gongxian Ding, Lieming Wang, Yang Yuan, Xiaobin Guo, Jun